Intermediate fibrosis staging in hepatitis C: a problem not overcome by optimal samples or pathologists’ expertise
Open Access
- 1 September 2015
- journal article
- research article
- Published by Elsevier in Annals of Hepatology
- Vol. 14 (5) , 652-657
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Liver biopsy: The best, not the gold standardJournal of Hepatology, 2009
- Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithmsWorld Journal of Gastroenterology, 2009
- Utilization rates, complications and costs of percutaneous liver biopsy: a population‐based study including 4275 biopsiesLiver International, 2008
- The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies: Table 1Gut, 2007
- A Systematic Review of the Quality of Liver Biopsy SpecimensAmerican Journal of Clinical Pathology, 2006
- Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis CGastroenterology, 2005
- A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis CHepatology, 2003
- Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infectionAmerican Journal of Gastroenterology, 2002
- Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective studyThe Lancet, 2001
- Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis CHepatology, 1994